BxPC3 Orthotopic Model


BxPC3 is a human pancreatic adenocarcinoma cell line that serves as a valuable model for studying pancreatic cancer. It retains key characteristics of pancreatic adenocarcinoma, including epithelial morphology, anchorage-independent growth, and expression of tumor markers. BxPC3 is commonly used to investigate pancreatic cancer biology, evaluate therapeutic strategies, and screen potential anti-cancer agents. This cell line provides insights into pancreatic cancer pathogenesis and aids in the development of targeted treatments for this aggressive disease.

Model Details

Cancer Type: Pancreatic Cancer
Model Name: BxPC3
Mouse Strain: Nu/Nu
Treatment Data Available: N/A

BxPC3 Survival

Survival of BxPC3 after orthotopic intrapancreatic injection of Nu/Nu mice (n=5)

Request Additional Syngeneic Model Data

Contact Us

Get Started.

Have questions about how TD2 can assist with your regulatory needs? Reach out to our
expert staff today to get started.

Skip to content